IL33 and asthma: Since most of previous studies on IL-33 blocking agents are at the stage of in vitro and animal testing, pharmacological evaluations to develop IL-33–blocking agents are still on-going (132) and some are in phase I–II clinical trials for asthma and chronic obstructive pulmonary disease (133).